Edoxaban for the management of elderly Japanese patients with atrial fibrillation ineligible for standard oral anticoagulant therapies: Rationale and design of the ELDERCARE-AF study-Reference-Cited by-同舟云学术

Edoxaban for the management of elderly Japanese patients with atrial fibrillation ineligible for standard oral anticoagulant therapies: Rationale and design of the ELDERCARE-AF study

Published:2017-12 Issue: Volume:194 Page:99-106
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Okumura Ken,Lip Gregory Y.H.,Akao Masaharu,Tanizawa Kimihiko,Fukuzawa Masayuki,Abe Kenji,Akishita Masahiro,Yamashita Takeshi

Funder

Daiichi Sankyo, Inc

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference40 articles.

1. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study;Wolf;Stroke,1991

2. Stroke severity in atrial fibrillation. The Framingham Study;Lin;Stroke,1996

3. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study;Go;JAMA,2001

4. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence;Miyasaka;Circulation,2006

5. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study;Chugh;Circulation,2014

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison between non-vitamin K oral antagonist versus warfarin in atrial fibrillation with and without valvular heart disease: a systematic review and meta-analysis;The Egyptian Heart Journal;2024-08-09

2. Pharmacokinetics of Edoxaban 15 mg in Very Elderly Patients with Nonvalvular Atrial Fibrillation: A Subanalysis of the ELDERCARE-AF Study;Thrombosis and Haemostasis;2024-04-19

3. Efficacy and Safety of Low‐Dose Edoxaban by Body Weight in Very Elderly Patients With Atrial Fibrillation: A Subanalysis of the Randomized ELDERCARE‐AF Trial;Journal of the American Heart Association;2024-02-06

4. The Efficacy and Safety of NOAC in Very Elderly Atrial Fibrillation Patients: Data From the Korean National Health Insurance Cohort Registry;Korean Circulation Journal;2024

5. Implications of Clinical Risk Phenotypes on the Management and Natural History of Atrial Fibrillation: A Report From the GLORIA‐AF;Journal of the American Heart Association;2023-10-17